ConductScience.org, home

Paper21995442

How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature.

Heckley GA and 3 others. BMC Cancer, 2011. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. Papers, record 21995442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21995442

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature.
PubMed
Journal
BMC Cancer
PubMed
Year
2011
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
1.82
iCite
Revised in PubMed
2025-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heckley GAGawain A
2Jarl JJohan
3Asamoah BOBenedict O
4G-Gerdtham UUlf

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alcohol DrinkingMajor topic
Liver NeoplasmsMajor topic
TemperanceMajor topic
Humans
Risk Factors
Risk Reduction Behavior

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112814203Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.Cancer Causes Control2003https://conductscience.org/library/papers/12814203PubMed
218260706Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC).Asian Pac J Cancer Prev2007https://conductscience.org/library/papers/18260706PubMed
316855004Abstaining from alcohol and labour market underperformance--have we forgotten the 'dry' alcoholics?Alcohol Alcohol2006https://conductscience.org/library/papers/16855004PubMed
417487833Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis.Int J Cancer2007https://conductscience.org/library/papers/17487833PubMed
59310563Bias in meta-analysis detected by a simple, graphical test.BMJ1997https://conductscience.org/library/papers/9310563PubMed
620717547On measurement of avoidable and unavoidable cost of alcohol: an application of method for estimating costs due to prior consumption.Int J Environ Res Public Health2010https://conductscience.org/library/papers/20717547PubMed
71626547Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.Am J Epidemiol1992https://conductscience.org/library/papers/1626547PubMed
83000590A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption.Cancer Res1986https://conductscience.org/library/papers/3000590PubMed
911509842Relation between average alcohol consumption and disease: an overview.Eur Addict Res2001https://conductscience.org/library/papers/11509842PubMed
107888442Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan.Epidemiology1995https://conductscience.org/library/papers/7888442PubMed
1115150901Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study data.Kurume Med J2004https://conductscience.org/library/papers/15150901PubMed
1217676579Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category.Stat Med2008https://conductscience.org/library/papers/17676579PubMed
136315225Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles.Cancer Res1983https://conductscience.org/library/papers/6315225PubMed

Download CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42860761Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.Liver Int2026https://conductscience.org/library/papers/42860761PubMed
41328189Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond.J Clin Exp Hepatol2025https://conductscience.org/library/papers/41328189PubMed
41171519A Higher Risk of Liver Cancer in Alcoholic Fatty Liver Disease than in Non-Alcoholic Fatty Liver Disease: an Analysis of the TriNetX Dabatase.J Gastrointest Cancer2025https://conductscience.org/library/papers/41171519PubMed
40692268Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus.Diabetes Metab J2025https://conductscience.org/library/papers/40692268PubMed
40378121What is the lifetime cost of alcohol consumption? an estimation of economic burden in Thailand.PLoS One2025https://conductscience.org/library/papers/40378121PubMed
40336003Thomasclavelia ramosa and alcohol-related hepatocellular carcinoma: a microbial culturomics study.Gut Pathog2025https://conductscience.org/library/papers/40336003PubMed
39823133An Overview of In Vitro Models of Alcohol-Related Hepatocellular Carcinoma.Cancer Med2025https://conductscience.org/library/papers/39823133PubMed
39653784Current and emerging strategies for the prevention of hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2025https://conductscience.org/library/papers/39653784PubMed
39362712Alcohol and Hepatocellular Carcinoma.Clin Liver Dis2024https://conductscience.org/library/papers/39362712PubMed
39000296Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon.Int J Mol Sci2024https://conductscience.org/library/papers/39000296PubMed
38201624Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/38201624PubMed
38180593Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition.Eur J Epidemiol2024https://conductscience.org/library/papers/38180593PubMed
37726886Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.Cell Adh Migr2023https://conductscience.org/library/papers/37726886PubMed
37426323Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.World J Gastroenterol2023https://conductscience.org/library/papers/37426323PubMed
37013506Overall lifestyle changes in adulthood are associated with cancer incidence in the Norwegian Women and Cancer Study (NOWAC) - a prospective cohort study.BMC Public Health2023https://conductscience.org/library/papers/37013506PubMed
36687124Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.World J Gastroenterol2023https://conductscience.org/library/papers/36687124PubMed
36545707The effects of moderate alcohol consumption on non-alcoholic fatty liver disease.Clin Mol Hepatol2023https://conductscience.org/library/papers/36545707PubMed
36001313Association Between Changes in Alcohol Consumption and Cancer Risk.JAMA Netw Open2022https://conductscience.org/library/papers/36001313PubMed
35673598Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges.J Hepatocell Carcinoma2022https://conductscience.org/library/papers/35673598PubMed
35207638Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.J Pers Med2022https://conductscience.org/library/papers/35207638PubMed

See all 43 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21995442

GET https://conductscience.org/api/papers/v1/21995442/cited_by?page=2